ArticleInternational urology and nephrology2016
Switching from subcutaneous insulin injection to oral vildagliptin administration in hemodialysis patients with type 2 diabetes: a pilot study.
Naoshi Yoshida et al.PubMed ↗Publisher ↗
No numbers read from the abstract.